BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $789,000 | -82.2% | 2,018,253 | 0.0% | 0.85% | -80.0% |
Q1 2016 | $4,440,000 | -3.9% | 2,018,253 | 0.0% | 4.24% | +16.8% |
Q4 2015 | $4,622,000 | -48.7% | 2,018,253 | 0.0% | 3.63% | -40.8% |
Q3 2015 | $9,001,000 | -20.2% | 2,018,253 | 0.0% | 6.13% | +21.9% |
Q2 2015 | $11,282,000 | +1.8% | 2,018,253 | 0.0% | 5.03% | +1.7% |
Q1 2015 | $11,080,000 | +1.7% | 2,018,253 | 0.0% | 4.95% | -42.6% |
Q4 2014 | $10,899,000 | -37.1% | 2,018,253 | 0.0% | 8.62% | -35.6% |
Q3 2014 | $17,337,000 | -34.8% | 2,018,253 | 0.0% | 13.38% | -38.3% |
Q2 2014 | $26,600,000 | +10.2% | 2,018,253 | 0.0% | 21.68% | +8.1% |
Q1 2014 | $24,138,000 | – | 2,018,253 | – | 20.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |